Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Lujan-Fryns syndrome (LFS) is characterized by intellectual disability, marfanoid habitus with disproportionate tall stature, minor facial anomalies and hypernasal speech. Initial screening of UPF3B in 397 families identified truncating and missense variants in four unrelated pedigrees (PMID:19238151). The nonsense allele c.1081C>T (p.Arg361Ter) underwent nonsense-mediated decay resulting in complete absence of UPF3B protein in patient lymphoblasts, and neuronal localization studies demonstrated UPF3B expression in dendritic spines critical for synaptic function (PMID:19238151).
A follow-up study of 28 males with a clinical diagnosis of LFS did not detect any causative UPF3B variants (PMID:26358559), challenging the specificity of UPF3B for classical LFS. Although functional data support a loss-of-function mechanism, the absence of replication in a larger cohort limits the clinical validity of UPF3B as a primary LFS gene. Key Take-home: UPF3B loss-of-function can manifest with LFS-like features but is rare; genetic diagnosis of LFS should prioritize MED12 and demonstrable X-linked segregation or pathogenic variants.
Gene–Disease AssociationLimitedUPF3B truncating and missense variants reported in four families (PMID:19238151) but absent in 28 clinically diagnosed LFS cases (PMID:26358559) Genetic EvidenceLimitedFour probands with private UPF3B variants; no replication in larger LFS cohort Functional EvidenceModerateNonsense c.1081C>T causes NMD and protein loss in patient cells, and neuronal localization supports disease mechanism (PMID:19238151) |